INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 117 filers reported holding INTERSECT ENT INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,739,000 | +14.0% | 54,100 | 0.0% | 0.25% | -2.0% |
| Q4 2018 | $1,525,000 | -1.9% | 54,100 | 0.0% | 0.25% | +40.2% |
| Q3 2018 | $1,555,000 | -26.7% | 54,100 | -4.4% | 0.18% | -22.8% |
| Q2 2018 | $2,120,000 | -8.7% | 56,600 | -4.2% | 0.23% | -15.9% |
| Q1 2018 | $2,323,000 | +21.3% | 59,100 | 0.0% | 0.28% | +9.5% |
| Q4 2017 | $1,915,000 | +4.0% | 59,100 | 0.0% | 0.25% | -13.1% |
| Q3 2017 | $1,841,000 | -26.1% | 59,100 | -33.7% | 0.29% | -32.2% |
| Q2 2017 | $2,490,000 | +83.5% | 89,100 | +12.6% | 0.43% | +51.2% |
| Q1 2017 | $1,357,000 | +37.8% | 79,100 | +27.1% | 0.28% | +26.9% |
| Q3 2016 | $985,000 | +22.5% | 62,213 | 0.0% | 0.22% | +13.8% |
| Q2 2016 | $804,000 | -32.0% | 62,213 | 0.0% | 0.20% | -30.5% |
| Q1 2016 | $1,182,000 | -18.9% | 62,213 | -4.0% | 0.28% | -17.1% |
| Q4 2015 | $1,458,000 | – | 64,813 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |